Showing 1,101 - 1,120 results of 1,680 for search '"myocardial"', query time: 0.07s Refine Results
  1. 1101

    Global Longitudinal Strain Value and its Association with Coronary Artery Disease Severity by Rohan G. Sonawane, C. K. Ponde

    Published 2025-01-01
    “…Depth-adjusted 2D images of the LV were taken in various views for offline measurement of 2D speckle-tracking myocardial strain. Global peak systolic strain was calculated by averaging six regional values from different views to measure longitudinal strain. …”
    Get full text
    Article
  2. 1102

    Hemodynamic Correlates of Late Systolic Flow Velocity Augmentation in the Carotid Artery by Kevin S. Heffernan, Wesley K. Lefferts, Jacqueline A. Augustine

    Published 2013-01-01
    “…Additional parameters included which is a forward travelling expansion/decompression wave of myocardial origin that produces suction, CCA single-point pulse wave velocity (PWV) as a measure of arterial stiffness, and CCA pressure augmentation index (AIx). …”
    Get full text
    Article
  3. 1103

    Atrial Fibrillation after Inhalational Lung Injury: A Troubling Complication of a Rare Problem by Ragesh Panikkath, Kenneth Nugent, Alejandro Perez-Verdia

    Published 2012-01-01
    “…These arrhythmias may reflect direct myocardial injury during and after exposure. Alternatively, multiple mechanisms can cause atrial fibrillation in lung diseases, including hypoxemia, acidemia, inflammatory mediators, and structural changes in the atria and ventricle, and these could lead to AF in inhalational lung injury cases. …”
    Get full text
    Article
  4. 1104

    LOX-1, OxLDL, and Atherosclerosis by Angela Pirillo, Giuseppe Danilo Norata, Alberico Luigi Catapano

    Published 2013-01-01
    “…In humans, LOX-1 gene polymorphisms were associated with increased susceptibility to myocardial infarction. Inhibition of the LOX-1 receptor with chemicals or antisense nucleotides is currently being investigated and represents an emerging approach for controlling OxLDL-LOX-1 mediated proatherogenic effects.…”
    Get full text
    Article
  5. 1105

    Extremely Unusual Coronary Involvement in Cardiac Sarcoidosis by Amanpreet Singh Wasir, Manish Bansal, Anand Jaiswal, Surbhi Pande, Abha Thakur, Haimanti Sarin, Kartikeya Bhargava

    Published 2024-07-01
    “…It also showed subendocardial late gadolinium enhancement localized to the inferior wall segments with 50%–75% transmural extent. 18-fluorodeoxyglucose (FDG) positron emission tomography showed multiple FDG-avid lymph nodes all over the body along with intense myocardial FDG uptake confined to the inferior wall. …”
    Get full text
    Article
  6. 1106

    Simultaneous transcatheter aortic valve implantation and femoral osteosynthesis: a case report by Yuki Mitsuta, Yukiko Okamura, Yosuke Miyamoto, Dai Tanahira

    Published 2025-01-01
    “…Preoperative management was carried out with attention to the risk of myocardial ischemia caused by bleeding or pain from the fracture. …”
    Get full text
    Article
  7. 1107

    Tea Polyphenols Regulate Key Mediators on Inflammatory Cardiovascular Diseases by Jun-ichi Suzuki, Mitsuaki Isobe, Ryuichi Morishita, Ryozo Nagai

    Published 2009-01-01
    “…In our laboratory, we performed oral administration of catechins into murine and rat models of cardiac transplantation, myocarditis, myocardial ischemia, and atherosclerosis to reveal the effects of catechins on the inflammation-induced ventricular and arterial remodeling. …”
    Get full text
    Article
  8. 1108

    Perioperative infarction during coronary bypass surgery: an attempt to refine the diagnostic criteria using data from a retrospective case–control study by Lars Niclauss, Liam-Kani Roulet, Piergiorgio Tozzi, Filip Dulguerov, Ziyad Gunga, Anna Nowacka, Matthias Kirsch

    Published 2025-01-01
    “…Objective The definition of coronary artery bypass graft (CABG)-associated myocardial infarction (MI) is controversial because the postoperative increases in cardiac enzyme activities are multifactorial in origin. …”
    Get full text
    Article
  9. 1109

    Functional Multipotency of Stem Cells: What Do We Need from Them in the Heart? by Pablo Díez Villanueva, Ricardo Sanz-Ruiz, Alberto Núñez García, María Eugenia Fernández Santos, Pedro L. Sánchez, Francisco Fernández-Avilés

    Published 2012-01-01
    “…Randomized clinical trials have demonstrated that stem cell therapy can improve cardiac recovery after the acute phase of myocardial ischemia and in patients with chronic ischemic heart disease, and several efficacy phase III trials with clinical endpoints are on their way. …”
    Get full text
    Article
  10. 1110

    Cardiovascular rehabilitation. Results in the cardiology service. by Juan José Navarro López, Roberto S. Vega Hernández., Claudio González Rodríguez., Teresa Rodríguez Rodríguez

    Published 2004-04-01
    “…<strong><br />Results </strong>: Out of the total of patient, 25 are males (83.3%), the diagnoses were: myocardium sharp attack, arterial hypertension with angina, myocardial revascularization and stable angina. In a highly significant way p &lt; 0,0001 double product varied as much at the end of the jogging and the ergometric parameters: the maxim body burden reached, tolerated and the total time of exercise. …”
    Get full text
    Article
  11. 1111

    Comorbidity and risk of cardiac events in patients with acute coronary syndrome by R.R. Komorovsky

    Published 2019-03-01
    “…The main outcomes were cardiac death and myocardial infarction. Results. A total of 150 (45 %) patients were found to have comorbidities. …”
    Get full text
    Article
  12. 1112

    Study of the Leading Causes of Death in Guanajay in the year 2013 by Jorge Julian Sánchez Fernández, Ana Lilia Cabrera Menéndez, Ailed Pérez Pi, José Carlos Merino Concepción

    Published 2015-06-01
    “…The three leading causes of death were malignant neoplasms, acute myocardial infarction and cerebrovascular disease. The top three locations of tumors were the lungs, colon and prostate. …”
    Get full text
    Article
  13. 1113

    Stem Cells for Cardiac Repair: Status, Mechanisms, and New Strategies by Ren Mingliang, Zhang Bo, Wang Zhengguo

    Published 2011-01-01
    “…The possible causes for the limited effects of stem cell in curing heart failure are the stem cells which have been transplanted into the ischemic heart muscle may suffer low survival rate, affected by inflammatory molecules, proapoptotic factor, and lack of nutrients and oxygen, and then the stem cells which home and have been completely transplanted to the site of myocardial infarction become very small. Therefore, through preconditioning of stem cells and appropriate choice of genes for mesenchymal stem cell modification to improve the survival rate of stem cells, ability in homing and promoting angiogenesis may become the newly effective strategies for the application of stem cells therapy in heart failure.…”
    Get full text
    Article
  14. 1114

    Cardioprotective effects of total and anthocyanin-rich extracts of Opuntia ficus-indica fruit on epinephrine-induced cardiac injury in rats by Leila Safaeian, Masoud Sadeghi-Dinani, Zahra Haghighatian, Mohammad-Bagher Fatahian, Marjan Khademizadeh

    Published 2024-12-01
    “…Objective: To examine the effect of fruit extracts of Opuntia ficus-indica on epinephrine-induced myocardial injury in rats. Methods: Rats were pre-treated with hydroalcoholic and anthocyanin-rich extracts (250, 500, and 1 000 mg/kg) orally for 16 days. …”
    Get full text
    Article
  15. 1115

    Management recommendations to reduce cardiac risk in chronic epilepsy by Trudy D. Pang, Richard L. Verrier, Steven C. Schachter

    Published 2025-03-01
    “…Diverse pathophysiological processes appear to be involved that include accelerated atherosclerosis, myocardial infarction, abnormal autonomic tone, heart failure, atrial and ventricular arrhythmias, and hyperlipidemia. …”
    Get full text
    Article
  16. 1116

    The Impact of Obesity on the Cardiovascular System by Imre Csige, Dóra Ujvárosy, Zoltán Szabó, István Lőrincz, György Paragh, Mariann Harangi, Sándor Somodi

    Published 2018-01-01
    “…Obesity leads to structural and functional changes of the heart, which causes heart failure. The altered myocardial structure increases the risk of atrial fibrillation and sudden cardiac death. …”
    Get full text
    Article
  17. 1117

    The Effects of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Disease Risks in Type 2 Diabetes Mellitus by Pegah Yousefzadeh, Xiangbing Wang

    Published 2013-01-01
    “…These agents may have the potential to lower blood pressure, improve lipid profile and endothelial dysfunction, decrease the macrophage-mediated inflammatory response, and prevent myocardial injury. Conclusion. DPP-4 inhibitors have some CV protective effects in type 2 diabetes mellitus (T2DM) in addition to their antidiabetic actions. …”
    Get full text
    Article
  18. 1118

    Interleukin-6 “Trans-Signaling” and Ischemic Vascular Disease: The Important Role of Soluble gp130 by Mario Luca Morieri, Angelina Passaro, Giovanni Zuliani

    Published 2017-01-01
    “…Large genetic human studies, using Mendelian randomization approaches, have clearly showed that IL-6 pathway is causally involved in the onset of myocardial infarction. At the same time, IL-6 pathway is divided into two arms: classic signaling (effective in hepatocytes and leukocytes) and trans-signaling (with ubiquitous activity). …”
    Get full text
    Article
  19. 1119

    Genotype-phenotype insights of pediatric dilated cardiomyopathy by Ying Dai, Yan Wang, Youfei Fan, Bo Han

    Published 2025-01-01
    “…Dilated cardiomyopathy (DCM) in children is a severe myocardial disease characterized by enlargement of the left ventricle or both ventricles with impaired contractile function. …”
    Get full text
    Article
  20. 1120

    Perioperative Risk: Short Review of Current Approach in Non Cardiac Surgery by Andreea Boghean, Cristian Guțu, Dorel Firescu

    Published 2025-01-01
    “…Quantification of surgical risk as low, intermediate, and high is useful in identifying the group of patients who are at risk of complications such as myocardial infarction, thrombosis, arrhythmias, heart failure, stroke or even death. …”
    Get full text
    Article